New Onset HFpEF and LVH Don’t Miss the Treatable Zebra: How to Diagnose and Treat Cardiac Amyloidosis in 2025

This session will guide the audience through how to evaluate and treat a patient with new a diagnosis of HFpEF and LVH . Left Ventricular Hypertrophy should more appropriately be denoted Left Ventricular Thickening. This session is part of the Core Cardiology track: sessions providing practical guidance for both cardiologists and the broader community of healthcare providers.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Target Specialties

Pricing

$399 – $1,399

$399 · $499 · $599 · $949 · $1,099 · $1,249 · $1,399

7 rates listed

$399
$499
$599
$949
$1,099
$1,249
$1,399

Listed by the provider · professional.heart.org

Enduring / On-demand
Credit · Up to 1.25 credits
MOC · Up to 1.25 points
$399–1,399

Released

Dec 1, 2025
Last day to claim credit

Dec 1, 2028 2 years left

New Onset HFpEF and LVH Don’t Miss the Treatable Zebra: How to Diagnose and Treat Cardiac Amyloidosis in 2025

Related courses

More from American Heart Association